Literature DB >> 29572812

The risk, burden, and management of non-communicable diseases in cerebral palsy: a scoping review.

Jennifer M Ryan1,2, Elizabeth Allen3, John Gormley4, Edward A Hurvitz5, Mark D Peterson5.   

Abstract

AIM: To examine the risk, burden, and management of non-communicable diseases (NCDs) among people with cerebral palsy (CP).
METHOD: Databases (Ovid MEDLINE, Embase Ovid, CINAHL Plus) were systematically searched up to August 2017. Data on the prevalence of risk factors for, and the burden and management of, cardiovascular diseases, diabetes, cancers, and respiratory diseases were extracted.
RESULTS: Thirty-six studies that examined the prevalence of risk factors among people with CP were identified. There was inconsistent evidence that people with CP had higher prevalence of metabolic risk factors such as hypertension, hyperlipidaemia, and obesity, but strong evidence that they participated in low levels of physical activity, compared with people without CP. Seven studies reported on the burden of NCDs. Adults with CP had a higher risk of NCDs, including stroke, chronic obstructive pulmonary disease, and other heart conditions, and death due to NCDs, including cancers, chronic obstructive pulmonary disease, stroke, and ischaemic heart disease, compared with the general population. Only one study reported on the management of NCD, specifically the uptake of breast cancer screening among females.
INTERPRETATION: The burden of NCDs is higher among adults with CP compared with the general population. Further research is required to determine the prevalence of metabolic risk factors and management of NCDs among people with CP. WHAT THIS PAPER ADDS: Adults with cerebral palsy (CP) have an increased risk of non-communicable diseases (NCDs) and increased risk of death because of NCDs. Evidence is inconsistent about the elevated prevalence of metabolic risk factors for NCDs. Evidence is consistent that people with CP participate in reduced physical activity. Only one study reported on management of NCD among people with CP. Available evidence suggests people with CP are less likely to receive preventive medicine.
© 2018 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac KeithPress.

Entities:  

Mesh:

Year:  2018        PMID: 29572812     DOI: 10.1111/dmcn.13737

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  10 in total

Review 1.  The Impact of Malnutrition on Hospitalized Children With Cerebral Palsy.

Authors:  Byron Alexander Foster; Jennifer E Lane; Elizabeth Massey; Michelle Noelck; Sarah Green; Jared P Austin
Journal:  Hosp Pediatr       Date:  2020-11-05

2.  [The need to act together in every way possible: inter-sector action in health and education for children living with the congenital Zika syndrome].

Authors:  Miriam Ribeiro Calheiros de Sá; Ana Carolina Dias Vieira; Barbara S Madeira Castro; Olivia Agostini; Tracey Smythe; Hannah Kuper; Maria Elisabeth Lopes Moreira; Martha Cristina Nunes Moreira
Journal:  Cad Saude Publica       Date:  2019-11-28       Impact factor: 1.632

3.  Effect of RaceRunning on cardiometabolic disease risk factors and functional mobility in young people with moderate-to-severe cerebral palsy: protocol for a feasibility study.

Authors:  Jennifer Ryan; Nicola Theis; Pelagia Koufaki; Shaun Phillips; Nana Anokye; Georgia Andreopoulou; Fiona Kennedy; Kavi C Jagadamma; Petra vanSchie; Hannah Dines; Marietta L van der Linden
Journal:  BMJ Open       Date:  2020-07-01       Impact factor: 2.692

4.  Prevalence of High-Burden Medical Conditions Among Young and Middle-Aged Adults With Pediatric-Onset Medical Conditions: Findings From US Private and Public Administrative Claims Data.

Authors:  Daniel G Whitney
Journal:  Int J Health Policy Manag       Date:  2019-11-01

5.  Noncommunicable disease among adults with cerebral palsy: A matched cohort study.

Authors:  Jennifer M Ryan; Mark D Peterson; Anthony Matthews; Nicola Ryan; Kimberley J Smith; Neil E O'Connell; Silvia Liverani; Nana Anokye; Christina Victor; Elizabeth Allen
Journal:  Neurology       Date:  2019-08-28       Impact factor: 9.910

6.  Mortality due to cardiovascular disease, respiratory disease, and cancer in adults with cerebral palsy.

Authors:  Jennifer M Ryan; Mark D Peterson; Nicola Ryan; Kimberley J Smith; Neil E O'connell; Silvia Liverani; Nana Anokye; Christina Victor; Elizabeth Allen
Journal:  Dev Med Child Neurol       Date:  2019-02-06       Impact factor: 5.449

7.  Risk of dementia in adults with cerebral palsy: a matched cohort study using general practice data.

Authors:  Kimberley J Smith; Mark D Peterson; Christina Victor; Jennifer M Ryan
Journal:  BMJ Open       Date:  2021-01-25       Impact factor: 2.692

8.  Population-based study on the prevalence and clinical profile of adults with cerebral palsy in Northern Ireland.

Authors:  Karen McConnell; Emma Livingstone; Oliver Perra; C Kerr
Journal:  BMJ Open       Date:  2021-01-08       Impact factor: 2.692

Review 9.  Vitamin D deficiency in children with cerebral palsy: A narrative review of epidemiology, contributing factors, clinical consequences and interventions.

Authors:  Kamel Awadh Alenazi
Journal:  Saudi J Biol Sci       Date:  2021-12-16       Impact factor: 4.052

10.  Acupuncture treatment on the motor area of the scalp for motor dysfunction in children with cerebral palsy: study protocol for a multicenter randomized controlled trial.

Authors:  Jun Wang; Wei Shi; Dhiaedin Khiati; Bingpei Shi; Xiaojuan Shi; Dandan Luo; Yin Wang; Rencai Deng; Huayu Huang; Jian Li; Weili Yan; Hong Yang
Journal:  Trials       Date:  2020-01-06       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.